pascal vranckx retweeted
Very nice editorial and interesting new issue!
Congratulations and good luck to @VranckxPascal for this important milestone.
Sure that he with the new editorial team will do a fantastic job for the journal and all the readers!
pascal vranckx retweeted
16. We hope you enjoyed this #EHJACVC tweetorial. Big thank you to Twitter Editors @krychtiukmd @mrubini @rafavidalperez @umityasarsinan1 👏
Now you're set to start #ACVC2021 in top form😉
@susannaprice @drmilicaa @mirvatalasnag @VijayKunadian @MihaiTrofenciuc @PabloJ #ACVC_ESC
pascal vranckx retweeted
15. The issue is completed by an important #COVID19 paper:
A study from Wuhan showed that peak levels of high sensitive troponin I and not admission levels predict in-hospital mortality in #COVID_19 patients with cardiac injury academic.oup.com/ehjacc/arti…
#EHJACVC
pascal vranckx retweeted
14. The third one is an excellent young #ACVC_ESC initiative evaluating the current status of #AcuteCardiovascularCare training in Europe:
Current status and needs for changes in critical care training: the voice of the young cardiologists academic.oup.com/ehjacc/arti…
#EHJACVC
pascal vranckx retweeted
13. The second position paper deals with the composition, structure and function of the #HeartTeam: a joint position paper of @escardio #ACVC_ESC #EAPCI @EACTS and @EACTA focusing on the patient with complex CAD requiring revascularisation academic.oup.com/ehjacc/arti…
#EHJACVC
pascal vranckx retweeted
12. The issue also features three excellent reviews and position papers:
The first one is a comprehensive educational review on cardiac tamponade - from pathophysiology and diagnosis to pericardiocentesis academic.oup.com/ehjacc/arti…
#EHJACVC
pascal vranckx retweeted
11. What is the prognostic relevance of pericardial effusion (PE) in #STEMI treated with pPCI?
In a large registry study from Italy, PE was not associated with mortality. Free wall rupture is rare but more frequent in patients with PE academic.oup.com/ehjacc/arti…
#EHJACVC
pascal vranckx retweeted
10. In this French analysis, Renaudier et al. showed that 14 of 150 VA-#ECMO patients suffered from acute mesenteric ischemia, with a 100% mortality. Risk factors included RRT and second shock, early enteral nutrition was protective academic.oup.com/ehjacc/arti…
#EHJACVC
pascal vranckx retweeted
9. In an IABP-SHOCK-II subanalysis, G Fürnau and @thiele_holger studied timing of IABP implantation.
They could show no outcome difference in #AMICS patients whether IABP was implanted pre or post pPCI academic.oup.com/ehjacc/arti…
#EHJACVC
pascal vranckx retweeted
8. Elena Collado et al. analysed the hospitalisation-related economic impact of patients with #CardiogenicShock in a reference centre.
Economic cost was significant, but with a low ratio of cost per life-year gained academic.oup.com/ehjacc/arti…
#EHJACVC
pascal vranckx retweeted
7.What's the long-term prognosis after AMI- #CardiogenicShock? A markedly ⬆️ rate of #HeartFailure hospitalisation & 1-yr mortality is the paramount finding of this study.
But among 1-yr survivors of MI, remaining 5-yr mortality was similar with/without CS
academic.oup.com/ehjacc/arti…
pascal vranckx retweeted
4. In the Spanish 5-center Red-Shock cohort, @m_rivaslasarte et al. provide external validation and comparison of the #CardShock and IABP-SHOCK II risk scores.
The authors demonstrate both were good predictors of in-hospital mortality in ACS-related CS academic.oup.com/ehjacc/arti…
pascal vranckx retweeted
3. In an editorial titled "Potential growth in cardiogenic shock research though an international registry collaboration", @seanvandiepen and Dave Morrow call for a Hub-of-Spokes model in #CardiogenicShock research academic.oup.com/ehjacc/arti…
#EHJACVC #CardioEd
pascal vranckx retweeted
1. Hot off the press - #EHJACVC Issue 1/2021 tweetorial 🔽
The issue opens with an editorial by new EiC @VranckxPascal, highlighting the aims of the journal, presenting the new editorial board and thanking @cvrints, former EiC academic.oup.com/ehjacc/arti…
#ACVC_ESC #cardiotwitter
Now in EHJ: Acute Cardiovascular Care. More data on the use of intravenous beta-blockers in STEMI.
IV Beta-blockers in STEMI patients with KILLIP class<3 in the acute phase is associated with a significant reduction in malignant arrhythmias without increase in cardiogenic shock.
Scientists warn of new coronavirus variant spreading across Europe ft.com/content/2782655a-0441… via @financialtimes
pascal vranckx retweeted
There’s been a lot of joking about getting a nasopharyngeal swab can be like a brain biopsy. Well, that actually happened jamanetwork.com/journals/jam… @JAMAOto







































